By liquefying the blood, tPA can not only facilitate its drainage/displacement but also reduce the risk of iatrogenic damage to photoreceptors during clot removal as well as the need for large retinotomies and the associated risk of retinal detachment, epiretinal membrane (ERM), and proliferative vitreoretinopathy [34]. This evidence concerns the gene PLAT and retinal detachment.